Volume 8, Issue 7
Opinion
Open Access

Scientific Opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed

First published: 29 July 2010
Citations: 137
Panel members: Hans Christer Andersson, Salvatore Arpaia, Detlef Bartsch, Josep Casacuberta, Howard Davies, Patrick du Jardin, Gerhard Flachowsky, Lieve Herman, Huw Jones, Sirpa Kärenlampi, Jozsef Kiss, Gijs Kleter, Harry Kuiper, Antoine Messéan, Kaare Magne Nielsen, Joe Perry, Annette Pöting, Jeremy Sweet, Christoph Tebbe, Atte Johannes von Wright, and Jean‐Michel Wal
Correspondence: gmo@efsa.europa.eu
Acknowledgement: The Panel wishes to thank the members of the Working Group on “The assessment of allergenicity of genetically modified foods” for the preparation of this Draft Scientific Opinion: Rob Aalberse, Hans Christer Andersson, Philippe Eigenmann, Ralf Einspanier, Karin Hoffmann‐Sommergruber, Gijs Kleter, Ilona Kryspin‐Sorensen, Martinus Lövik, Clare Mills, Jean‐Marie Saint‐Remy, Willem Seinen, Daniel Soeria‐Atmadja (until September 2009), Ingrid Van der Meer, Jean‐Michel Wal (Chair) and John Warner (until September 2008); the following experts for their contribution on specialised issues: Dominique Kaiserlian (January 2007), Jean‐Paul Lallès (July 2008), Gabriel Peltre (July 2007), André Penninks (January 2007); and EFSA's staff members Ellen Van Haver and Antonio Fernandez Dumont for the support provided to this EFSA scientific output
Adoption date: 30 June 2010
Published date: 29 July 2010
Question number: EFSA‐Q‐2005‐125
On request from: EFSA

Abstract

The weight‐of‐evidence, case‐by‐case approach is considered the most appropriate way of assessing the allergenicity of genetically modified (GM) food and feed. This scientific opinion discusses various aspects to increase the strength and accuracy of this approach, including the latest developments pertaining to clinical aspects of allergic reactions, structural aspects of GM food and feed and in silico approaches, as well as IgE binding studies and cell‐based methods, profiling techniques and animal models. In this context, conclusions and recommendations are provided to update and complement current risk assessment strategies for the allergenicity assessment of newly expressed protein(s) and whole GM food and feed. In summary, it is recommended that with regard to the search for sequence homology and structural similarities, the local alignment method with a known allergen with a threshold of 35% sequence identity over a window of at least 80 amino acids is considered a minimal requirement. When IgE binding tests are considered necessary, e.g. when there is sequence homology and/or structure similarity with known allergens, the use of individual sera from allergic individuals rather than pooled sera is recommended. In addition to the pepsin resistance test, it is recommended that the resistance to digestion of the newly expressed proteins is evaluated using other in vitro digestibility tests mimicking physiological conditions of humans. Finally, when the recipient of the introduced gene is allergenic, in order to compare the allergenicty of the whole GM plant with that of its appropriate comparator(s), it is recommended that relevant characterised endogenous allergens are included in the comparative compositional analysis of the GM plant and its appropriate comparator(s). Proposals for the use of additional testing that may improve the weight‐of‐evidence approach and suggestions for further evaluation of new promising methods that are as yet in an early phase of development are also addressed.

Number of times cited according to CrossRef: 137

  • Safety evaluation of the food enzyme xylanase from the genetically modified Trichoderma reesei strain RF5703, EFSA Journal, 10.2903/j.efsa.2020.5974, 18, 1, (2020).
  • Safety evaluation of the food enzyme maltogenic amylase from the genetically modified Bacillus licheniformis strain DP‐Dzr50, EFSA Journal, 10.2903/j.efsa.2020.5972, 18, 1, (2020).
  • Safety evaluation of the food enzyme xylanase from the genetically modified Aspergillus luchuensis Inui strain RF7398, EFSA Journal, 10.2903/j.efsa.2020.5971, 18, 1, (2020).
  • Safety evaluation of the food enzyme xylose isomerase from the genetically modified Streptomyces rubiginosus strain DP‐Pzn37, EFSA Journal, 10.2903/j.efsa.2020.5978, 18, 1, (2020).
  • Assessment of genetically modified soybean SYHT0H2 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2012‐111), EFSA Journal, 10.2903/j.efsa.2020.5946, 18, 1, (2020).
  • Safety evaluation of the food enzyme lysophospholipase from the genetically modified Aspergillus niger strain NZYM‐LP, EFSA Journal, 10.2903/j.efsa.2020.6130, 18, 5, (2020).
  • Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from the genetically modified Trichoderma reesei strain RF5427, EFSA Journal, 10.2903/j.efsa.2020.6127, 18, 6, (2020).
  • Safety evaluation of the food enzyme α‐amylase from the Parageobacillus thermoglucosidasius strain DP‐Gzb47, EFSA Journal, 10.2903/j.efsa.2020.6129, 18, 5, (2020).
  • Assessment of genetically modified soybean MON 87705 × MON 87708 × MON 89788, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2015‐126), EFSA Journal, 10.2903/j.efsa.2020.6111, 18, 5, (2020).
  • Safety evaluation of the food enzyme triacylglycerol lipase from the genetically modified Ogataea polymorpha strain DP‐Jzk33, EFSA Journal, 10.2903/j.efsa.2020.6048, 18, 3, (2020).
  • Safety evaluation of the food enzyme α‐amylase from the genetically modified Pseudomonas fluorescens strain BD15754, EFSA Journal, 10.2903/j.efsa.2020.6043, 18, 3, (2020).
  • Safety evaluation of the food enzyme α‐amylase from the genetically modified Bacillus amyloliquefaciens strain DP‐Czb53, EFSA Journal, 10.2903/j.efsa.2020.6185, 18, 10, (2020).
  • Safety evaluation of the food enzyme isoamylase from a Dyella sp. strain, EFSA Journal, 10.2903/j.efsa.2020.6250, 18, 10, (2020).
  • Scientific Opinion on application EFSA‐GMO‐NL‐2016‐132 for authorisation of genetically modified of insect‐resistant and herbicide‐tolerant soybean DAS–81419–2 × DAS–44406–6 for food and feed uses, import and processing submitted in accordance with Regulation (EC) No 1829/2003 by Dow Agrosciences LCC, EFSA Journal, 10.2903/j.efsa.2020.6302, 18, 11, (2020).
  • Safety evaluation of the food enzyme α‐amylase from the genetically modified Bacillus licheniformis strain DP‐Dzb45, EFSA Journal, 10.2903/j.efsa.2020.6311, 18, 11, (2020).
  • Safety evaluation of the food enzyme Phospholipase A2 from the genetically modified Trichoderma reesei strain RF8793, EFSA Journal, 10.2903/j.efsa.2020.6310, 18, 11, (2020).
  • Exploring beta amyloid cleavage enzyme‐1 inhibition and neuroprotective role of benzimidazole analogues as anti‐alzheimer agents, Journal of the Chinese Chemical Society, 10.1002/jccs.201900200, 67, 5, (864-873), (2019).
  • Mechanical Properties of Muscles around the Shoulder in Breast Cancer Patients: Intra‐rater and Inter‐rater Reliability of the MyotonPRO, PM&R, 10.1002/pmrj.12227, 12, 4, (374-381), (2019).
  • Taxonomic review and phylogenetic inference elucidate the evolutionary history of Mesozoic Procercopidae, with new data from the Cretaceous Jehol Biota of NE China (Hemiptera, Cicadomorpha), Journal of Zoological Systematics and Evolutionary Research, 10.1111/jzs.12349, 58, 1, (174-193), (2019).
  • Identifying Near‐Infrared Persistent Luminescence in Cr3+‐Doped Magnesium Gallogermanates Featuring Afterglow Emission at Extremely Low Temperature, Advanced Optical Materials, 10.1002/adom.201901848, 8, 6, (2019).
  • Safety evaluation of the food enzyme 4‐phytase from a genetically modified Trichoderma reesei (strain DP‐Nzt55), EFSA Journal, 10.2903/j.efsa.2019.5826, 17, 10, (2019).
  • Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from Trichoderma reesei (strain DP‐Nzh63), EFSA Journal, 10.2903/j.efsa.2019.5825, 17, 10, (2019).
  • Safety evaluation of the food enzyme triacylglycerol lipase from Trichoderma reesei (strain RF10625), EFSA Journal, 10.2903/j.efsa.2019.5837, 17, 10, (2019).
  • Safety evaluation of the food enzyme beta‐galactosidase from Bacillus sp. (strain M3‐1), EFSA Journal, 10.2903/j.efsa.2019.5827, 17, 10, (2019).
  • Safety assessment of the process Marcato, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials, EFSA Journal, 10.2903/j.efsa.2019.5828, 17, 10, (2019).
  • Safety assessment of the process PETman, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials, EFSA Journal, 10.2903/j.efsa.2019.5829, 17, 10, (2019).
  • Safety assessment of the process Reco‐Kavala, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials, EFSA Journal, 10.2903/j.efsa.2019.5830, 17, 10, (2019).
  • Safety assessment of the process Poly Recycling, based on recoSTAR PET FG technology, used to recycle post‐consumer PET into food contact materials, EFSA Journal, 10.2903/j.efsa.2019.5836, 17, 10, (2019).
  • Safety evaluation of the food enzyme cellulase from Trichoderma reesei (strain DP‐Nzc36), EFSA Journal, 10.2903/j.efsa.2019.5839, 17, 10, (2019).
  • Literature review in support of adjuvanticity/immunogenicity assessment of proteins, EFSA Supporting Publications, 10.2903/sp.efsa.2019.EN-1551, 16, 1, (2019).
  • Allergenicity prediction of novel and modified proteins: Not a mission impossible! Development of a Random Forest allergenicity prediction model, Regulatory Toxicology and Pharmacology, 10.1016/j.yrtph.2019.104422, (104422), (2019).
  • Safety evaluation of the food enzyme glucan 1,4‐α‐maltotetraohydrolase from Bacillus licheniformis (strain DP‐Dzr46), EFSA Journal, 10.2903/j.efsa.2019.5684, 17, 5, (2019).
  • Safety evaluation of the food enzyme α‐amylase from a genetically modified strain of Bacillus licheniformis (DP‐Dzb25), EFSA Journal, 10.2903/j.efsa.2019.5900, 17, 11, (2019).
  • Assessment of genetically modified soybean MON 87751 × MON 87701 × MON 87708 × MON 89788 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐128), EFSA Journal, 10.2903/j.efsa.2019.5847, 17, 11, (2019).
  • Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐UK‐2006‐34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272, EFSA Journal, 10.2903/j.efsa.2019.5844, 17, 11, (2019).
  • Safety evaluation of the food enzyme glucan 1,4‐α‐maltotetraohydrolase from Bacillus licheniformis (strain DP‐Dzf24), EFSA Journal, 10.2903/j.efsa.2019.5739, 17, 6, (2019).
  • Safety evaluation of the food enzyme β‐glucanase, xylanase and cellulase from Mycothermus thermophiloides (strain NZYM‐ST), EFSA Journal, 10.2903/j.efsa.2019.5631, 17, 3, (2019).
  • Safety evaluation of the food enzyme glucose isomerase from Streptomyces murinus (strain NZYM‐GA), EFSA Journal, 10.2903/j.efsa.2019.5547, 17, 1, (2019).
  • Administrative guidance on the submission of applications for renewal of authorisation of genetically modified food and feed under Articles 11 and 23 of Regulation (EC) No 1829/2003, EFSA Supporting Publications, 10.2903/sp.efsa.2019.EN-1668, 16, 6, (2019).
  • Assessment of genetically modified soybean MON 87708 × MON 89788 × A5547‐127, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐135), EFSA Journal, 10.2903/j.efsa.2019.5733, 17, 7, (2019).
  • Flash point of binary mixtures of chlorinated hydrocarbons with toluene and their predictability with existing mixing rule, Process Safety Progress, 10.1002/prs.12127, 0, 0, (2019).
  • In Vitro and In Silico Approaches to Generating and Identifying Angiotensin-Converting Enzyme I Inhibitory Peptides from Green Macroalga Ulva lactuca, Marine Drugs, 10.3390/md17040204, 17, 4, (204), (2019).
  • Relevance of new scientific information (Santos‐Vigil et al., 2018) in relation to the risk assessment of genetically modified crops with Cry1Ac, EFSA Supporting Publications, 10.2903/sp.efsa.2019.EN-1504, 15, 11, (2018).
  • Risk assessment of new sequencing information for genetically modified soybean A2704‐12, EFSA Journal, 10.2903/j.efsa.2018.5496, 16, 11, (2018).
  • Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Aspergillus oryzae (strain NZYM‐FA), EFSA Journal, 10.2903/j.efsa.2018.5480, 16, 11, (2018).
  • Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Trichoderma reesei (strain DP‐Nzd22), EFSA Journal, 10.2903/j.efsa.2018.5479, 16, 11, (2018).
  • Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐SO), EFSA Journal, 10.2903/j.efsa.2018.5478, 16, 11, (2018).
  • Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐OC), EFSA Journal, 10.2903/j.efsa.2018.5477, 16, 11, (2018).
  • Assessment of genetically modified maize MZHG0JG for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2016‐133), EFSA Journal, 10.2903/j.efsa.2018.5469, 16, 11, (2018).
  • Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9, EFSA Journal, 10.2903/j.efsa.2018.5425, 16, 9, (2018).
  • Risk assessment of new sequencing information on genetically modified carnation FLO‐40689‐6, EFSA Journal, 10.2903/j.efsa.2018.5424, 16, 9, (2018).
  • Assessment of genetically modified soybean MON 87751 for food and feed uses under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2014‐121), EFSA Journal, 10.2903/j.efsa.2018.5346, 16, 8, (2018).
  • Assessment of genetically modified maize 4114 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2014‐123), EFSA Journal, 10.2903/j.efsa.2018.5280, 16, 5, (2018).
  • Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Aspergillus niger (strain XEA), EFSA Journal, 10.2903/j.efsa.2018.5228, 16, 4, (2018).
  • Safety evaluation of the food enzyme maltogenic amylase from a genetically modified Bacillus subtilis (strain NZYM‐SM), EFSA Journal, 10.2903/j.efsa.2018.5171, 16, 5, (2018).
  • Safety evaluation of the food enzyme aqualysin 1 from a genetically modified Bacillus subtilis (strain LMGS 25520), EFSA Journal, 10.2903/j.efsa.2018.5170, 16, 5, (2018).
  • Safety evaluation of food enzyme xylanase from a genetically modified Bacillus subtilis (strain LMG S‐27588), EFSA Journal, 10.2903/j.efsa.2018.5169, 16, 5, (2018).
  • Safety evaluation of food enzyme glucan 1,4‐α‐maltohydrolase produced with a genetically modified Bacillus subtilis (strain MAM), EFSA Journal, 10.2903/j.efsa.2018.5168, 16, 5, (2018).
  • Systematic miRNome profiling reveals differential microRNAs in transgenic maize metabolism, Environmental Sciences Europe, 10.1186/s12302-018-0168-7, 30, 1, (2018).
  • Approaches to assess IgE mediated allergy risks (sensitization and cross-reactivity) from new or modified dietary proteins, Food and Chemical Toxicology, 10.1016/j.fct.2017.12.025, 112, (97-107), (2018).
  • Q-X1-P-X2 motif search for potential celiac disease risk has poor selectivity, Regulatory Toxicology and Pharmacology, 10.1016/j.yrtph.2018.09.021, (2018).
  • Safety evaluation of the food enzyme xylanase from a genetically modified Bacillus subtilis strain TD160(229), EFSA Journal, 10.2903/j.efsa.2018.5008, 16, 1, (2018).
  • Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from a genetically modified Aspergillus niger (strain NZYM‐BW), EFSA Journal, 10.2903/j.efsa.2018.5446, 16, 10, (2018).
  • Safety of the food enzyme glucoamylase from a genetically modified Aspergillus niger (strain NZYM‐BF), EFSA Journal, 10.2903/j.efsa.2018.5450, 16, 10, (2018).
  • Safety evaluation of the food enzyme α‐amylase from a genetically modified Aspergillus niger (strain NZYM‐MC), EFSA Journal, 10.2903/j.efsa.2018.5451, 16, 10, (2018).
  • Assessment of genetically modified maize MON 87403 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐BE‐2015‐125), EFSA Journal, 10.2903/j.efsa.2018.5225, 16, 3, (2018).
  • Safety evaluation of the food enzyme glucose oxidase from a genetically modified Aspergillus oryzae (strain NZYM‐KP), EFSA Journal, 10.2903/j.efsa.2018.5319, 16, 7, (2018).
  • Safety evaluation of the food enzyme α‐amylase from a genetically modified Bacillus licheniformis (strain NZYM‐AV), EFSA Journal, 10.2903/j.efsa.2018.5318, 16, 7, (2018).
  • Safety evaluation of the food enzyme alpha‐amylase from a genetically modified Bacillus licheniformis (strain NZYM‐AN), EFSA Journal, 10.2903/j.efsa.2018.5317, 16, 7, (2018).
  • Risk assessment of new sequencing information on genetically modified carnation FLO‐40685‐2, EFSA Journal, 10.2903/j.efsa.2018.5396, 16, 7, (2018).
  • Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health, EFSA Journal, 10.2903/j.efsa.2018.5327, 16, 7, (2018).
  • Safety evaluation of the food enzyme α‐amylase from a genetically modified Aspergillus niger (strain NZYM‐SB), EFSA Journal, 10.2903/j.efsa.2018.5320, 16, 7, (2018).
  • Heat and Pressure Treatments on Almond Protein Stability and Change in Immunoreactivity after Simulated Human Digestion, Nutrients, 10.3390/nu10111679, 10, 11, (1679), (2018).
  • Safety evaluation of the food enzyme peroxidase obtained from soybean (Glycine max) hulls, EFSA Journal, 10.2903/j.efsa.2017.5119, 15, 12, (2017).
  • Risk assessment of new sequencing information on genetically modified soybean event 40‐3‐2, EFSA Journal, 10.2903/j.efsa.2017.4968, 15, 8, (2017).
  • Risk assessment of new sequencing information on genetically modified soybean event 305423, EFSA Journal, 10.2903/j.efsa.2017.4967, 15, 8, (2017).
  • Safety evaluation of the food enzyme β‐amylase from genetically modified Bacillus licheniformis strain NZYM‐JA, EFSA Journal, 10.2903/j.efsa.2017.4896, 15, 8, (2017).
  • Safety evaluation of the food enzyme pullulanase from genetically modified Bacillus subtilis strain NZYM‐AK, EFSA Journal, 10.2903/j.efsa.2017.4895, 15, 8, (2017).
  • Definition and Design of Hypoallergenic Foods, Molecular Allergy Diagnostics, 10.1007/978-3-319-42499-6, (487-511), (2017).
  • Assessment of endogenous allergenicity of genetically modified plants exemplified by soybean – Where do we stand?, Food and Chemical Toxicology, 10.1016/j.fct.2017.01.014, 101, (139-148), (2017).
  • Scientific opinion on an application by Dow AgroSciences LLC (EFSA‐GMO‐NL‐2012‐106) for the placing on the market of genetically modified herbicide‐tolerant soybean DAS‐44406‐6 for food and feed uses, import and processing under Regulation (EC) No 1829/2003, EFSA Journal, 10.2903/j.efsa.2017.4738, 15, 3, (2017).
  • Scientific Opinion on an application by Dow AgroSciences LLC (EFSA‐GMO‐NL‐2011‐91) for the placing on the market of genetically modified herbicide‐tolerant soybean DAS‐68416‐4 for food and feed uses, import and processing under Regulation (EC) No 1829/2003, EFSA Journal, 10.2903/j.efsa.2017.4719, 15, 3, (2017).
  • Immune analysis of cry1Ab-genetically modified potato by in-silico analysis and animal model, Food Science and Biotechnology, 10.1007/s10068-017-0181-4, 26, 5, (1437-1445), (2017).
  • Guidance on allergenicity assessment of genetically modified plants, EFSA Journal, 10.2903/j.efsa.2017.4862, 15, 6, (2017).
  • Safety evaluation of the food enzyme pullulanase from Pullulanibacillus naganoensis strain AE‐PL, EFSA Journal, 10.2903/j.efsa.2017.5009, 15, 10, (2017).
  • Safety evaluation of the food enzyme β‐amylase obtained from soybean (Glycine max), EFSA Journal, 10.2903/j.efsa.2017.4757, 15, 5, (2017).
  • Safety evaluation of the food enzyme β‐amylase obtained from barley (Hordeum vulgare), EFSA Journal, 10.2903/j.efsa.2017.4756, 15, 5, (2017).
  • Safety evaluation of the food enzyme endo‐1,4‐β‐xylanase from genetically modified Aspergillus niger strain XYL, EFSA Journal, 10.2903/j.efsa.2017.4755, 15, 5, (2017).
  • Safety evaluation of a β‐amylase food enzyme obtained from wheat (Triticum spp.), EFSA Journal, 10.2903/j.efsa.2017.4754, 15, 5, (2017).
  • Ligand binding to an Allergenic Lipid Transfer Protein Enhances Conformational Flexibility resulting in an Increase in Susceptibility to Gastroduodenal Proteolysis, Scientific Reports, 10.1038/srep30279, 6, 1, (2016).
  • Bioactive hydrolysates from bovine blood globulins: Generation, characterisation, and in silico prediction of toxicity and allergenicity, Journal of Functional Foods, 10.1016/j.jff.2016.03.031, 24, (142-155), (2016).
  • Scientific Opinion on an application by Dow AgroSciences (EFSA‐GMO‐NL‐2013‐116) for placing on the market of genetically modified insect‐resistant soybean DAS‐81419‐2 for food and feed uses, import and processing under Regulation (EC) No 1829/2003, EFSA Journal, 10.2903/j.efsa.2016.4642, 14, 12, (2016).
  • Risk assessment of new sequencing information on GM maize event DAS‐59122‐7, EFSA Journal, 10.2903/j.efsa.2016.4639, 14, 12, (2016).
  • Scientific Opinion on an application by DOW AgroSciences LLC (EFSA‐GMO‐NL‐2010‐89) for placing on the market the genetically modified herbicide‐tolerant maize DAS‐40278‐9 for food and feed uses, import and processing under Regulation (EC) No 1829/2003, EFSA Journal, 10.2903/j.efsa.2016.4633, 14, 12, (2016).
  • Oyster mortality, EFSA Journal, 10.2903/j.efsa.2015.4122, 13, 6, (2015).
  • Guidance on the agronomic and phenotypic characterisation of genetically modified plants, EFSA Journal, 10.2903/j.efsa.2015.4128, 13, 6, (2015).
  • Statement on the suitability of the BEEHAVE model for its potential use in a regulatory context and for the risk assessment of multiple stressors in honeybees at the landscape level, EFSA Journal, 10.2903/j.efsa.2015.4125, 13, 6, (2015).
  • Risk profile related to production and consumption of insects as food and feed, EFSA Journal, 10.2903/j.efsa.2015.4257, 13, 10, (2015).
  • Scientific Opinion on an application (Reference EFSA‐GMO‐NL‐2011‐100) for the placing on the market of the herbicide‐tolerant, increased oleic acid genetically modified soybean MON 87705 × MON 89788 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Monsanto, EFSA Journal, 10.2903/j.efsa.2015.4178, 13, 7, (2015).
  • Scientific Opinion on an application (EFSA‐GMO‐BE‐2011‐98) for the placing on the market of herbicide‐tolerant genetically modified soybean FG72 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience, EFSA Journal, 10.2903/j.efsa.2015.4167, 13, 7, (2015).
  • See more